Yamato Sajiki

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Stage-dependent changes in prostaglandin E₂ in tick saliva determine its immunosuppressive effects.

Stage-dependent changes in prostaglandin E₂ in tick saliva determine its immunosuppressive effects.

Journal: Ticks and tick-borne diseases
Published: December 08, 2025

Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves.

Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves.

Journal: Vaccines
Published: February 05, 2023

Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.

Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.

Journal: Journal of virology
Published: January 04, 2023

Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system.

Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system.

Journal: Veterinary research
Published: December 12, 2022

Prostaglandin E2-Induced Immune Suppression via Cytotoxic T-Lymphocyte Antigen 4 in Paratuberculosis.

Prostaglandin E2-Induced Immune Suppression via Cytotoxic T-Lymphocyte Antigen 4 in Paratuberculosis.

Journal: Infection and immunity
Published: September 14, 2022

Suppressive effects of Ixodes persulcatus sialostatin L2 against Borrelia miyamotoi-stimulated immunity.

Suppressive effects of Ixodes persulcatus sialostatin L2 against Borrelia miyamotoi-stimulated immunity.

Journal: Ticks and tick-borne diseases
Published: January 10, 2022

Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.

Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.

Journal: The Journal of veterinary medical science
Published: November 18, 2021

Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.

Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.

Journal: Scientific reports
Published: November 12, 2021

Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.

Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.

Journal: PloS one
Published: May 23, 2021

Prostaglandin-related immune suppression in cattle.

Prostaglandin-related immune suppression in cattle.

Journal: Veterinary immunology and immunopathology
Published: December 14, 2020

The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis.

The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis.

Journal: The Journal of veterinary medical science
Published: December 07, 2020

Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.

Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.

Journal: ImmunoHorizons
Published: October 18, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026